Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 130Thoracic 30Gastrointestinal 28Breast 18Gynecologic 17Dermatologic 17Genitourinary 14Sarcoma 4Lymphoid 4Plasma cell 1Other solid neoplasm 1Other hematologic neoplasm 1Classical hematology 1CNS 1

Conditions

Multiple Myeloma 206Lymphoma 26Hematologic Neoplasms 21Recurrence 15Lymphoma, Non-Hodgkin 12Leukemia, Lymphocytic, Chronic, B-Cell 11Neoplasms, Plasma Cell 10Leukemia, Myeloid, Acute 10Precursor Cell Lymphoblastic Leukemia-Lymphoma 9Neoplasms 9Immunoglobulin Light-chain Amyloidosis 9Prostatic Neoplasms 8Hodgkin Disease 8Ovarian Neoplasms 7Myelodysplastic Syndromes 7Lymphoma, Mantle-Cell 7Lung Neoplasms 7Breast Neoplasms 7Smoldering Multiple Myeloma 6Melanoma 6Lymphoma, Large B-Cell, Diffuse 6Leukemia, Plasma Cell 6Leukemia, Myelogenous, Chronic, BCR-ABL Positive 5Waldenstrom Macroglobulinemia 4Lymphoma, Follicular 4Leukemia 4Colorectal Neoplasms 4Colonic Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Urinary Bladder Neoplasms 3

Interventions

pembrolizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Squamous Cell Carcinoma of Head and Neck × Plasma cell × 30 days × Clear all
NCT04354246 2026-05-12

COM902 (A TIGIT Inhibitor) in Subjects With Advanced Malignancies

Compugen Ltd

Phase 1 Completed
94 enrolled
GastrointestinalGynecologicHead & NeckPlasma cellThoracic

Squamous Cell Carcinoma of Head and Neck, Colonic Neoplasms, Lung Neoplasms, Multiple Myeloma, Ovarian Neoplasms, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡